Tag: CE Mark

August 7, 2019

Nemaura Announces First SugarBEAT Device Shipments

Nemaura Medical (NASDAQ:NMRD) has announced the first shipments of its SugarBEAT devices to diabetic and prediabetic patients in the United...
May 29, 2019

Nemaura Receives CE Mark Approval of SugarBEAT

Nemaura Medical (NASDAQ:NMRD) has announced it has received CE Mark approval for SugarBEAT, a non-invasive device for diabetics and pre-diabetics....
June 12, 2018

Dexcom G6 CGM System Receives CE Mark

Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom...